Works matching IS 1175-3277 AND VI 22 AND IP 5 AND DT 2022

Results: 10

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 567, doi. 10.1007/s40256-022-00540-x

By:

Alahmed, Abdullah A.;
Lauffenburger, Julie C.;
Vaduganathan, Muthiah;
Aldemerdash, Ahmed;
Ting, Clara;
Fatani, Nayyra;
Fanikos, John;
Buckley, Leo F.

Publication type:

Article

Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 557, doi. 10.1007/s40256-022-00536-7

By:

Huang, Langjing;
Yu, Zhihua;
Liu, Mei;
Shang, Xiaoke

Publication type:

Article

Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 577, doi. 10.1007/s40256-022-00542-9

By:

Krittayaphong, Rungroj;
Permsuwan, Unchalee

Publication type:

Article

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 545, doi. 10.1007/s40256-022-00534-9

By:

Desai, Nihar R.;
Campbell, Caresse;
Electricwala, Batul;
Petrou, Margaret;
Trueman, David;
Woodcock, Fionn;
Cristino, Joaquim

Publication type:

Article

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 497, doi. 10.1007/s40256-022-00532-x

By:

Edelberg, Jay M.;
Sehnert, Amy J.;
Mealiffe, Matthew E.;
del Rio, Carlos L.;
McDowell, Robert

Publication type:

Article

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 463, doi. 10.1007/s40256-022-00531-y

By:

Fabris, Enrico;
Selvarajah, Abi;
Tavenier, Annerieke;
Hermanides, Rik;
Kedhi, Elvin;
Sinagra, Gianfranco;
van't Hof, Arnoud

Publication type:

Article

Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 511, doi. 10.1007/s40256-022-00530-z

By:

Suah, Boon-Hao;
Lee, Zhi-Yan;
Teo, Yao Hao;
Teo, Yao Neng;
Syn, Nicholas L. X.;
Soh, Rodney Y. H.;
Yeo, Leonard L. L.;
Tan, Benjamin Y. Q.;
Ho, Jamie Sin-Ying;
Li, Tony Y. W.;
Lee, Chi-Hang;
Chan, Mark Y.;
Yeo, Tiong-Cheng;
Wong, Raymond C. C.;
Chai, Ping;
Sia, Ching-Hui

Publication type:

Article

Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 475, doi. 10.1007/s40256-022-00529-6

By:

Lacoste, Jordan L.;
Szymanski, Thomas W.;
Avalon, Juan Carlo;
Kabulski, Galen;
Kohli, Utkarsh;
Marrouche, Nassir;
Singla, Atul;
Balla, Sudarshan;
Jahangir, Arshad

Publication type:

Article

Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 535, doi. 10.1007/s40256-022-00525-w

By:

Abumayyaleh, Mohammad;
Demmer, Jonathan;
Krack, Carina;
Pilsinger, Christina;
El-Battrawy, Ibrahim;
Behnes, Michael;
Aweimer, Assem;
Mügge, Andreas;
Lang, Siegfried;
Akin, Ibrahim

Publication type:

Article

The Effect of Vasopressin and Methylprednisolone on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 5, p. 523, doi. 10.1007/s40256-022-00522-z

By:

Abdelazeem, Basel;
Awad, Ahmed K.;
Manasrah, Nouraldeen;
Elbadawy, Merihan A.;
Ahmad, Soban;
Savarapu, Pramod;
Abbas, Kirellos Said;
Kunadi, Arvind

Publication type:

Article